Barzegar Behrooz, A.; Talaie, Z.; Jusheghani, F.; Łos, M.J.; Klonisch, T.; Ghavami, S.
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. Int. J. Mol. Sci. 2022, 23, 1353.
https://doi.org/10.3390/ijms23031353
AMA Style
Barzegar Behrooz A, Talaie Z, Jusheghani F, Łos MJ, Klonisch T, Ghavami S.
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. International Journal of Molecular Sciences. 2022; 23(3):1353.
https://doi.org/10.3390/ijms23031353
Chicago/Turabian Style
Barzegar Behrooz, Amir, Zahra Talaie, Fatemeh Jusheghani, Marek J. Łos, Thomas Klonisch, and Saeid Ghavami.
2022. "Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma" International Journal of Molecular Sciences 23, no. 3: 1353.
https://doi.org/10.3390/ijms23031353
APA Style
Barzegar Behrooz, A., Talaie, Z., Jusheghani, F., Łos, M. J., Klonisch, T., & Ghavami, S.
(2022). Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. International Journal of Molecular Sciences, 23(3), 1353.
https://doi.org/10.3390/ijms23031353